Business Description
The fund aims to mirror the results of an index that tracks pharmaceutical companies listed on the S&P Total Market Index. To achieve this, it puts at least 80% of its assets into the stocks that make up that index, using a selective approach rather than holding every single security. This gives investors focused exposure to the pharmaceutical sector of the broader U.S. stock market.
